Eosinophilic granulomatosis with polyangiitis and severe cardiac involvement in a patient surviving for 34 years

References

• Churg J, Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol. 1951; Mar-Apr27(2):277–301.
   PubMed Web of Science ®Google Scholar
• Bourgarit A, Toumelin PL, Pagnoux C, Cohen P, Mahr A, Guern VL, Mouthon L, Guillevin L, French Vasculitis Study Group Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients. Medicine (Baltimore). 2005;84(5):323–330. doi:10.1097/01.md.0000180793.80212.17.
   PubMed Web of Science ®Google Scholar
• Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, Gross WL, Guillevin L, Jayne D, Mahr A, European Vasculitis Study Group (EUVAS), et al. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systemic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis. 2008;67(7):1004–1010. doi:10.1136/ard.2007.071936.
   PubMed Web of Science ®Google Scholar
• Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, Thibult N, Casassus P. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: a prospective study in 342 patients. Medicine (Baltimore). 1996;75(1):17–28. doi:10.1097/00005792-199601000-00003.
   PubMed Web of Science ®Google Scholar
• Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33(8):1094–1100. doi:10.1002/art.1780330806.
   PubMed Web of Science ®Google Scholar
• Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Toumelin P, French Vasculitis Study Group (FVSG) The five-factor score revisited. Assessment of prognosis of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) Cohort. Medicine (Baltimore). 2011;90(1):19–27. doi:10.1097/MD.0b013e318205a4c6.
   PubMed Web of Science ®Google Scholar
• Moosig F, Bremer JP, Hellmich B, Holle JU, Holl-Ulrich K, Laudien M, Matthis C, Metzler C, Nölle B, Richardt G, et al. A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients. Ann Rheum Dis. 2013;72(6):1011–1017. doi:10.1136/annrheumdis-2012-201531.
   PubMed Web of Science ®Google Scholar
• Ford JA, Aleatany Y, Gewurz-Singer O. Therapeutic advances in eosinophilic granulomatosis with polyangiitis. Curr Opin Rheumatol. 2022;34(3):158–164. doi:10.1097/BOR.0000000000000873.
   PubMed Web of Science ®Google Scholar
• Solans-Laqué R, Rodriguez-Carballeira M, Rios-Blanco JJ, Fraile G, Sáez-Comet L, Martinez-Zapico A, Frutos B, Solanich X, Fonseca-Aizpuru E, Pasquau-Liaño F, et al. Comparison of the Birmingham Vasculitis Activity Score and the Five-Factor Score to Assess Survival in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: a Study of 550 Patients From Spain (REVAS Registry). Arthritis Care Res (Hoboken). 2020;72(7):1001–1010. doi:10.1002/acr.23912.
   PubMed Web of Science ®Google Scholar
• Ozaki S. ANCA-associated vasculitis: diagnostic and therapeutic strategy. Allergol Int. 2007;56(2):87–96. 200 doi:10.2332/allergolint.R-07-141.
   PubMedGoogle Scholar
• Gayraud M, Guillevin L, Le Toumelin P, Cohen P, Lhote  F, Casassus P, Jarrousse B, the French Vasculitis Study Group Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome. Arthritis Rheumatism. 2001;44(3):666–675.  doi:10.1002/1529-0131(200103)44:3<666::AID-ANR116>3.0.CO;2-A.
   PubMed Web of Science ®Google Scholar
• Chumbley L, Harrison E, DeRemee R. Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Mayo Clin Proc. 1977;52:477–484.
   PubMed Web of Science ®Google Scholar
• Pagnoux C, Mahr A, Cohen P, Guillevin L. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitis. Medicine (Baltimore). 2005;84(2):115–128. doi:10.1097/01.md.0000158825.87055.0b.
   PubMed Web of Science ®Google Scholar
• Comarmond C, Pagnoux C, Khellaf M, Cordier J-F, Hamidou M, Viallard J-F, Maurier F, Jouneau S, Bienvenu B, Puéchal X, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum. 2013;65(1):270–281. doi:10.1002/art.37721.
   PubMed Web of Science ®Google Scholar
• Neumann T, Manger B, Schmid M, Kroegel C, Hansch A, Kaiser WA, Reinhardt D, Wolf G, Hein G, Mall G, et al. Cardiac involvement in Churg-Strauss syndrome Impact of endomyocarditis. Medicine (Baltimore). 2009;88(4):236–243. doi:10.1097/MD.0b013e3181af35a5.
   PubMed Web of Science ®Google Scholar
• Szczeklik W, Miszalski-Jamka T, Mastalerz L, Sokolowska B, Dropinski J, Banys R, Hor KN, Mazur W, Musial J. Multimodality assessment of cardiac involvement in Churg-Strauss syndrome patients in clinical remission. Circ J. 2011;75(3):649–655. doi:10.1253/circj.cj-10-0772.
   PubMed Web of Science ®Google Scholar
• Tsurikisawa N, Taniguchi T, Saito H, Himeno H, Ishibashi A, Suzuki S, Akiyama K. Treatment of Churg–Strauss syndrome with high-dose intravenous immunoglobulin. Ann Allergy Asthma Immunol. 2004;92(1):80–87. doi:10.1016/S1081-1206(10)61714-0.
   PubMed Web of Science ®Google Scholar
• Tsurikisawa N, Saito H, Tsuburai T, Oshikata C, Ono E, Mitomi H, Akiyama K. Differences in regulatory T cells between Churg-Strauss syndrome and chronic eosinophilic pneumonia with asthma. J Allergy Clin Immunol. 2008;122(3):610–616. doi:10.1016/j.jaci.2008.05.040.
   PubMed Web of Science ®Google Scholar
• Tsurikisawa N, Saito H, Oshikata C, Tsuburai T, Akiyama K. High-dose intravenous immunoglobulin treatment increases regulatory T cells in patients with eosinophilic granulomatosis with polyangiitis. J Rheumatol. 2012;39(5):1019–1025. doi:10.3899/jrheum.110981.
   PubMed Web of Science ®Google Scholar
• Tsurikisawa N, Saito H, Oshikata C, Tsuburai T, Akiyama K. High-dose intravenous immunoglobulin therapy for eosinophilic granulomatosis with polyangiitis. Clin Transl Allergy. 2014;4:38–45. doi:10.1186/2045-7022-4-38.
   PubMed Web of Science ®Google Scholar
• Tsurikisawa N, Oshikata C, Watanabe M, Fukuda N, Yamaguchi T, Kiyohara H, Kaneko T. Clinical Features of Patients with Active Eosinophilic Granulomatosis with Polyangiitis Successfully Treated with Mepolizumab. Int Arch Allergy Immunol. 2021;182(8):744–756. doi:10.1159/000514505.
   PubMed Web of Science ®Google Scholar
• Tsurikisawa N, Oshikata C, Kinoshita A, Tsuburai T, Saito H. Long-term prognosis of 121 patients with eosinophilic granulomatosis with polyangiitis in Japan. J Rheumatol. 2017;44(8):1206–1215. doi:10.3899/jrheum.161436.
   PubMed Web of Science ®Google Scholar
• Amelotti N, Mapelli M, Guglielmo M, Pires MIFB, Campodonico J, Majocchi B, Ribatti V, Vettor G, Baggiano A, Catto V, et al. What’s behind your eosinophilic myocarditis? A case of Churg-Strauss syndrome diagnosed during acute heart failure. ESC Heart Fail. 2023;10(1):709–715. doi:10.1002/ehf2.14172.
   PubMedGoogle Scholar
• Samson M, Puéchal X, Devilliers H, Ribi C, Cohen P, Bienvenu B, Terrier B, Pagnoux C, Mouthon L, Guillevin L, et al. Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factors. Autoimmun Rev. 2014;13(9):945–953. doi:10.1016/j.autrev.2014.08.002.
   PubMed Web of Science ®Google Scholar
• Vemuri P, Greenberger PA, Patterson R. Churg-Strauss syndrome: survival for 26 years. Ann Allergy Asthma Immunol. 2002;88(6):640–643. doi:10.1016/S1081-1206(10)61898-4.
   PubMed Web of Science ®Google Scholar
• Van Dellen RG. Can you top this? 37-year survival of patient with Churg-Strauss syndrome. Ann Allergy Asthma Immunol. 2004;92(6):676. doi:10.1016/S1081-1206(10)61438-X.
   PubMed Web of Science ®Google Scholar
• Taira K, Tsunoda R, Watanabe T, Fujino A, Ogyu A, Ashikawa K. An autopsy case of isolated eosinophilic coronary periarteritis: a limited form of Churg-Strauss syndrome or a new entity? Intern Med. 2005;44(6):586–589. doi:10.2169/internalmedicine.44.586.
   PubMed Web of Science ®Google Scholar
• Setoguchi M, Okishige K, Sugiyama K, Shimura T, Maeda M, Aoyagi H, Kurabayashi M, Azegami K, Hagiyama H, Isobe M. Sudden cardiac death associated with Churg-Strauss syndrome. Circ J. 2009;73(12):2355–2359. doi:10.1253/circj.cj-08-0926.
   PubMed Web of Science ®Google Scholar
• Tuzov A, Zaitsev K, Nachman R, Hiss J. Sudden death due to eosinophilic arteritis of a major coronary artery. Harefuah. 2012;151:159–161.
   PubMedGoogle Scholar
• Plenzig S, Heinbuch S, Held H, Verhoff MA, Lux C. A case of fatal perimyocarditis due to a rare disease. Forensic Sci Med Pathol. 2017;13(4):454–458. doi:10.1007/s12024-017-9920-3.
   PubMed Web of Science ®Google Scholar
• Val-Bernal JF, Mayorga M, García-Alberdi E, Pozueta JA. Churg-Strauss syndrome and sudden cardiac death. Cardiovasc Pathol. 2003;12(2):94–97. doi:10.1016/s1054-8807(02)00157-6.
   PubMed Web of Science ®Google Scholar